Open access
Oct 2026
Bivalent CK2 Inhibition as a Potent Strategy Against SARS-CoV-2 and Other Coronaviruses
Dennis Salomon Lopez Molina, N. Ahnou, R. Brillet et al.
· bioRxiv · 0 citations
3 papers indexed here
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
Open access
Sep 2026
Barriers to Viral Hepatitis Elimination and New Strategies to Overcome Them in Low- and Middle-Income Countries.
Chronic infections with hepatitis B virus (HBV), hepatitis C virus (HCV), and hepatitis D virus (HDV) are major causes of cirrhosis and hepatocellular carcinoma (HCC) worldwide. The greatest burden is borne by low- and middle-income countries (LMICs). Despite the availability of highly effective preventive tools, simpl...
E. Vo-Quang, Maud Lemoine, J. Pawlotsky
· Journal of Hepatology · 0 citations
Open access
Sep 2026
Detection of a Nirsevimab-Resistant RSV-B Variant (F:K68Q) in an Adult with Severe Infection
F:K68Q appears to be rare among circulating RSV-B strains based on available global sequence surveillance data (GISAID), and its detection in a monoclonal antibody-naïve patient reinforces the hypothesis that this substitution may circulate independently of nirsevimab exposure.
N. de Prost, M. Le Goff, P. Cappy et al.
· Infectious Disease and Thera... · 0 citations